Clinical Trials in Atlanta

Showing 2421-2440 of 9,468 trials

A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program

NCT03350711

The goal of this study is to rapidly identify subjects who are eligible for the Microbiota Enrichment Program (MEP) at Emory in Atlanta, Georgia. This general screening protocol will be used to screen potential subjects for the Emory MEP and will be conducted at the Emory Clinic, the Hope Clinic of the Emory Vaccine Center and/or Emory affiliated hospitals. An electronic database will be created to capture demographic and medical information about individuals who are reaching out to obtain fecal microbiota transplant (FMT) and pre-screen these potential study participants for current and upcoming studies within MEP.

Clostridium Difficile Infection

Emory University200 participantsStarted Sep 2018

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Decatur, Georgia, United States

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

NCT04972981

The primary objectives of this study are to identify the recommended phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), and to characterize the safety and the tolerability of ADCT-901.

Advanced Solid Tumors

ADC Therapeutics S.A.30 participantsStarted Sep 2021

Denver, Colorado, United States • New Haven, Connecticut, United States • Atlanta, Georgia, United States +10 more locations

A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

Find Trials by Condition in Atlanta

Parkinson's Foundation PD GENEration Genetic Registry

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

StimRouter Registry Clinical Protocol

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium